A new blood test can cheaply and quickly distinguish between the mosquito-borne Zika and dengue viruses, researchers reported Wednesday, giving public health officials a valuable tool to track the spread of outbreaks and prepare for the possible consequences of the different infections.
Want more information on dengue combo test? Feel free to contact us.
The test, which was described in the journal Science Translational Medicine, relies on a simple paper strip, and researchers hope it can eventually be purchased for less than $1. The scientists who developed the test are at work to commercialize it and production would need to be scaled up before it could be deployed widely.
advertisement
Knowing which disease is spreading in an area is crucial for public health responses and research. But the Zika-dengue distinction is all the more important because Zika, unlike dengue, can cause severe birth defects and can be transmitted through sex, meaning it is vital for pregnant women to know which virus they have and for their sexual partners to identify their infections as well.
The problem is that Zika and dengue are similar; with some tests, the viruses cross-react, meaning that a dengue sample might produce a positive Zika test. They also trigger similar symptoms, including fever, headaches, and body pain. Samples often need to be sent to state labs to confirm the infection, which is expensive, time-consuming, and not realistic on a mass scale. That made it challenging to accurately track the recent Zika outbreak as it swept through South and Central America.
The new test exploits a quirk in how the viruses affect the body. Zika and the four strains of dengue each cause infected cells to release a slightly different version of a protein called NS1.
advertisement
For the test, antibodies that can uniquely identify those specific Zika or dengue NS1 proteins are embedded onto a paper strip, along with gold nanoparticles. The end result is that if the virus is present in the sample, a red dot will appear on the strip.
The test works best when analyzing serum a component of blood that can be easily separated out in health clinics but the researchers said it should also work on blood samples.
All you do is mix the serum with a solution and you dunk a paper strip into it, said Kimberly Hamad-Schifferli, an engineer at the University of Massachusetts, Boston, and visiting scientist at the Massachusetts Institute of Technology, who helped lead the research. You wait 15 minutes and you look for the appearance of a colored dot.
The Zika test accurately identified infections in 81 percent of positive samples and incorrectly identified an infection in negative samples 14 percent of the time.
NewslettersYour daily dose of news in health and medicine.
Please enter a valid address.
Privacy PolicyThe test can also differentiate among the four strains of dengue. Getting infected with one strain, or serotype, doesnt protect someone from contracting another strain later on, and those multiple infections increase the risk that the person will develop a much more severe illness called dengue hemorrhagic fever.
Being able to distinguish the four serotypes is very important for epidemiology purposes and to know what viruses are circulating in an environment, said Lee Gehrke, an engineer at MIT and one of the leaders of the research.
Currently, each paper strip is built to pick up on only one virus, so it would require five different versions to identify exactly what virus was causing an infection. But the researchers said theyre exploring how they could compile all five tests into one strip.
Nikos Vasilakis, a Zika expert at the University of Texas Medical Branch at Galveston who was not involved in developing the test, said the tests cost and the simplicity could make it a widely used tool in the parts of the world where these viruses circulate. The cost per strip now is in the $5 range, but the researchers said they expect that to drop with scaled-up production.
Are you interested in learning more about elisa hcv test? Contact us today to secure an expert consultation!
The test will be in a single dollar range, which is the biggest advantage in a resource-poor countries, Vasilakis said. The other advantage is that its very easy to use.
The researchers traveled to places in Central and South America and India to validate their test on samples from patients with confirmed infections. The papers long list of authors includes many scientists from those countries who helped the researchers secure samples for testing.
The number of new Zika cases has dwindled since the major outbreak in the Americas in and , but experts anticipate future outbreaks. The researchers also said they plan to apply the platform they used to build the Zika and dengue test to come up with diagnostic tests for other viruses.
In the case of a positive result, one should consult with their doctor to consider the first stage of treatment. The dengue test has been shown to be accurate in 98% of cases, clearly demonstrating its reliability. Certain medical factors may influence the result of the dengue test, for instance, previous dengue fever infections or infection with another arbovirus. If concerned then the individual should consult a doctor before taking the test in order to ensure accurate interpretation of the results.
The dengue fever diagnostic test detects two classes of antibodies, immunoglobulin G and M, in the serum/plasma or blood through the use of specific complementary antibody markers. Diagnosis may require multiple tests as the bodys immune system produces varying levels of antibodies over the course of the illness. The test will take approximately 20 minutes to provide a result.
The dengue fever diagnostic test detects two classes of antibodies, immunoglobulin G and M, in the serum/plasma or blood through the use of specific complementary antibody markers. Diagnosis may require multiple tests as the bodys immune system produces varying levels of antibodies over the course of the illness. The test will take approximately 20 minutes to provide a result.
In the case of a positive result, one should consult with their doctor to consider the first stage of treatment. The dengue test has been shown to be accurate in 98% of cases, clearly demonstrating its reliability. Certain medical factors may influence the result of the dengue test, for instance, previous dengue fever infections or infection with another arbovirus. If concerned then the individual should consult a doctor before taking the test in order to ensure accurate interpretation of the results.
AccuQuik promotes the use of the dengue IgG/IgM rapid diagnostic test.
Dengue fever is a painful and debilitating disease caused by the dengue virus. The tropical disease is transmitted by the Aedes aegypti mosquito causing a range of mild to severe symptoms. The basic symptoms include a high fever, headaches, pain behind the eyes, joint and muscle pain, nausea, vomiting, skin rash and mild nose bleeds.
As the disease progresses, a state known as dengue hemorrhagic fever develops which is associated with a high fever, bleeding nose, and gums, liver enlargement, damage to lymph and blood vessels and circulatory system failure. Eventually, the infected individual will encounter serious bleeding and will go into shock, followed shortly by death.
There is currently no vaccine against dengue fever however precautions can be taken to avoid contracting the disease. Preventing mosquito bites is a direct method of prevention, for example using mosquito repellants, wearing long-sleeved clothes and using mosquito nets. An indirect method of prevention is through the reduction of the mosquito population by removing breeding opportunities such as stagnant water bodies found in cans and flower pots.
Individuals with weakened immune systems, such as HIV patients, are at greater risk.
The incidence of dengue has increased dramatically in recent decades with over 40% of the worlds population now at risk. The disease is now endemic in more than 100 countries in Africa, the Americas, the Eastern Mediterranean, South-east Asia, and the Western Pacific.
Visiting the doctor, resting and drinking plenty of fluids are advised. There is currently no specific medicine to treat dengue fever however pain relievers containing acetaminophen can be effective. Treatment should not include aspirin as this will worsen the bleeding.
If the patients become severely dehydrated they should be admitted to the hospital where they may need to have fluids administered through a drip into the arm. Infected individuals should also take extra precaution in avoiding mosquito bites in order to help prevent the spread of the disease to others.
Around 20% of individuals infected with severe dengue die, but with access to medical care, this figure can be reduced to 1%. Research investigating the forecast for dengue and its movements is ongoing, as climate change is increasing the global access of the mosquito. The WHO aims to reduce the dengue incidence by 50% by .
For more information on treating dengue consult the Eliminating Dengue Program website at http://www.eliminatedengue.com/program.
For more elisa test hivinformation, please contact us. We will provide professional answers.